| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 9 |
| 1 | SACUBITRIL AND VALSARTAN | 9 |
| 2 | FUROSEMIDE | 8 |
| 3 | ASPIRIN | 7 |
| 4 | METOPROLOL | 7 |
| 5 | METOPROLOL TARTRATE | 7 |
| 6 | ADALIMUMAB | 6 |
| 7 | ASPIRIN 325 MG | 6 |
| 8 | ASPIRIN 81 MG | 6 |
| 9 | CARVEDILOL | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PSYLLIUM HUSK | 1 | 0.0007 |
| 1 | TENECTEPLASE | 1 | 0.0006 |
| 2 | RANOLAZINE | 5 | 0.0005 |
| 3 | PATISIRAN | 1 | 0.0004 |
| 4 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| 5 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 6 | BRINZOLAMIDE/BRIMONIDINE TARTRATE | 1 | 0.0002 |
| 7 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 8 | ACETAZOLAMIDE SODIUM | 1 | 0.0002 |
| 9 | ACLIDINIUM BROMIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-anginal [EPC] | 5 | 0.0005 |
| 1 | PCSK9 Inhibitor [EPC] | 9 | 0.0003 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 4 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 5 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |